[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021)
Global Cancer Statistics 2020: Globocan Estimates
of Incidence and Mor-tality Worldwide for 36 Cancers
in 185 Countries. CA: A Cancer Journal for Clinicians
, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
李岩. 高危型人乳头瘤病毒感染者宫颈病变程度与阴道内环境的关系[J]. 南昌大学学报(医学版), 2015, 55(2): 47-50.
|
[3]
|
张华东, 张显峰, 刘桂琴, 等. miR-128-3p在宫颈癌中的表达及其发病机制[J]. 临床与病理杂志, 2018, 38(7): 1405-1410.
|
[4]
|
刘伟姣, 罗一平, 曾燕. 阴道乳酸杆菌数量、高危型人乳头瘤病毒载量与宫颈病变的关系[J]. 黑龙江医学, 2016, 40(6): 512, 513.
|
[5]
|
张旭梅, 李芹, 柳露, 等. 阴道微生态与高危型HPV感染和宫颈病变的关系[J]. 中国妇幼保健, 2018, 33(8): 1739-1741.
|
[6]
|
孟令昊, 胥秋艳, 李科, 等. 1990~2019年中国女性宫颈癌疾病负担变化的分析[J]. 中国循证医学杂志, 2021, 21(6): 648-653.
|
[7]
|
谈红英, 马建婷. 阴道微生态变化与宫颈人乳头瘤病毒感染的相关性研究进展[J]. 中华生殖与避孕杂志, 2017, 37(5): 418-422.
|
[8]
|
Fontecha, N., Carmen Carmen, M., Andia, D., et al.
(2017) RNA Extraction Method Is Crucial for Human Papillomavirus E6/E7 Oncogenes Detection. Virology
Journal, 14, Article No. 50. https://doi.org/10.1186/s12985-017-0720-x
|
[9]
|
Tommasino, M. (2014) The Human Papillomavirus Family and Its Role in Carcinogenesis. Seminars in Cancer Biology, 26, 13-21. https://doi.org/10.1016/j.semcancer.2013.11.002
|
[10]
|
Stanley, M. (2010) Pathology and Epidemiology of HPV In-fection in Females. Gynecologic Oncology, 117, S5-S10.
https://doi.org/10.1016/j.ygyno.2010.01.024
|
[11]
|
McBride, A.A. and Warburton, A. (2017) The Role of Integra-tion in Oncogenic Progression of HPV-Associated Cancers. PLOS Pathogens, 13, e1006211. https://doi.org/10.1371/journal.ppat.1006211
|
[12]
|
Mighty, K.K. and Laimins, L.A. (2014) The Role of
Human Papillomaviruses in Oncogenesis. In: Chang,
M. and Jeang, K.T., Eds., Viruses and Human Cancer,
Vol. 193, Springer, Berlin, Heidelberg, 135-148.
https://doi.org/10.1007/978-3-642-38965-8_8
|
[13]
|
Yeo-The, N.S.L., Ito, Y. asnd Jha, S. (2018) High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis. International Journal of Molecular Sciences, 19, Article 1706.
https://doi.org/10.3390/ijms19061706
|
[14]
|
Luo, R.Z., Chen, S.L., Li, M., et al. (2021) HPV E6/E7 mRNA in Situhybridization in Endocervical Adenocarcinoma: Implications for Prognosis and Diagnosis. Cancer Cell International, 21, 19-29.
https://doi.org/10.1186/s12935-021-02349-1
|
[15]
|
Arbyn, M., Weiderpass, E., Bruni, L., et al. (2020) Estimates of Incidence and Mortality of Cervical Cancer in 2018: A Worldwide Analysis. The Lancet Global Health, 8, e191-e203. https://doi.org/10.1016/S2214-109X(19)30482-6
|
[16]
|
WHO (2013) Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention, 2013: World Health Organization, Geneva.
|
[17]
|
Maine, D., Hurlburt, S. and Greeson, D. (2011) Cervical Cancer Prevention in the 21st Century: Cost Is Not the Only Issue. Ameri-can Journal of Public Health, 101, 1549-1555. https://doi.org/10.2105/AJPH.2011.300204
|
[18]
|
WHO (2016) Human Papillomavirus (HPV) and Cervical Cancer.
http://210.26.175.175:8088/ssnppnb2hi4dthixs64dvmjwwkzbonzrwe2jonzwg2ltonfuc4z3poy9/28146625/
|
[19]
|
Bruni, L., et al. (2017) ICO/IARC Information
Centre on HPV and Cancer (HPV Information Centre).
Human Papillomavirus and Related Diseases in the
World. Summary Report 2017.
http://www.hpvcentre.net/statistics/reports/XWX.pdf
|
[20]
|
Doorbar, J., et al. (2012) The Biology and Life-Cycle of Hu-man Papillomaviruses. Vaccine, 30, F55-F70.
https://doi.org/10.1016/j.vaccine.2012.06.083
|
[21]
|
Kim, G. (2017) Harald zur Hausen’s Experiments on
Human Papillomavirus Causing Cervical Cancer
(1976-1987). In: Embryo Project Encyclopedia.
https://embryo.asu.edu/pages/harald-zur-
hausens-experiments-human-papillomavirus-causing
-cervical-cancer-1976-1987
|
[22]
|
Khoury, T., Mari, A., Nseir, W., et al. (2019)
Neutrophil-to-Lymphocyte Ratio Is Independently
Associated with Inflammatory Activity and Fibrosis
Grade in Nonalcoholic Fatty Liver Disease. European
Journal of Gastroenter-ology & Hepatology, 31, 1110-1115. https://doi.org/10.1097/MEG.0000000000001393
|
[23]
|
Tian, Q.F., et al. (2014) MicroRNA Detection in Cervical Exfoliated Cells as a Triage for Human Papillomavirus-Positive Women. Jour-nal of the National Cancer Institute, 106, dju241. https://doi.org/10.1093/jnci/dju241
|
[24]
|
Fontecha, N., Hernáez, S., Andía, D. and Cisterna, R. (2016) Assessment of Human Papillomavirus E6/E7 Oncogene Expression as Cervical Disease Biomarker. BMC Cancer, 16, Article No. 852.
https://doi.org/10.1186/s12885-016-2885-x
|
[25]
|
叶丽君, 喻长法, 蔡莎莎, 等. 高危型人乳头瘤病毒E6/E7mRNA联合液基细胞学检查在宫颈病变诊断中的应用[J]. 中国慢性病预防与控制, 2017, 25(7): 499-501.
|
[26]
|
Broccolo, F., et al. (2013) Comparison of Oncogenic HPV Type-Specific Viral DNA Load and E6/E7 mRNA Detection in Cervical Samples: Results from a Multicenter Study. Journal of Medical Virology, 85, 472-482.
https://doi.org/10.1002/jmv.23487
|